Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2019
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
N06BA14
|
| gptkbp:CASNumber |
90212-80-9
|
| gptkbp:chemicalFormula |
C10H15NO2
|
| gptkbp:contraindication |
severe renal impairment
end-stage renal disease |
| gptkbp:genericName |
solriamfetol
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sunosi
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Jazz_Pharmaceuticals
|
| gptkbp:mechanismOfAction |
dopamine-norepinephrine reuptake inhibitor
|
| gptkbp:pregnancyCategory |
not assigned (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
anxiety headache decreased appetite |
| gptkbp:synonym |
JZP-110
|
| gptkbp:usedFor |
narcolepsy
excessive daytime sleepiness obstructive sleep apnea |
| gptkbp:bfsParent |
gptkb:Jazz_Pharmaceuticals
gptkb:Solriamfetol |
| gptkbp:bfsLayer |
7
|